F
34
-2
EXR
51
-4
EMC
68
-21
INTU
69
-5
TRIP
26
-8
DHR
56
-6
VNO
55
-6
CF
56
5
KO
52
-10
CAT
46
-4
SYY
53
-4
STZ
32
-2
AVB
57
-2
SHW
34
-21
L
39
-2
RRC
62
-3
ZBH
48
-6
LYB
16
-2
LB
37
-7
XRX
32
-5
F
34
-2
EXR
51
-4
EMC
68
-21
INTU
69
-5
TRIP
26
-8
DHR
56
-6
VNO
55
-6
CF
56
5
KO
52
-10
CAT
46
-4
SYY
53
-4
STZ
32
-2
AVB
57
-2
SHW
34
-21
L
39
-2
RRC
62
-3
ZBH
48
-6
LYB
16
-2
LB
37
-7
XRX
32
-5
Financhill
Back

Genmab AS Stock Predictions

Sleep well at night with 7 stellar stocks to buy and hold forever

Get the complete list FREE for a limited time.
Buy
57

GMAB
Genmab AS

Last Price:
$22.82
Seasonality Move:
4.05%

7 Day Trial

ALL ACCESS PASS

$ 7

7 Stocks to Buy and Hold Forever

The result is a select group of high-quality blue-chip stocks.

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 43.2% based on the past 16 years of stock performance.
  • Genmab AS has risen higher in 10 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GMAB] share price is $22.82. The Score for GMAB is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • GMAB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 43.2% based on the past 16 years of stock performance.

Genmab AS Stock Rating

Buy
57
Genmab AS (GMAB) is a Buy

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 10 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%

Genmab AS Stock Price History

Is GMAB stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GMAB is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
28.56
52-Week Low:
17.24

Prediction Charts

Market Cap:
14.1B
Price in USD:
22.82
Volume:
1.1M
Beta:
0.70

Technical Analysis

SMA50:
20.48
SMA100:
20.62
SMA200:
21.79
52-Wk Change:
-13.59%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 22.82 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-27 21.34 21.28 21.38 20.95
May-28 20.74 21.19 21.21 20.73
May-29 21.17 21.32 21.42 21.12
May-30 21.14 20.95 21.18 20.57
Jun-2 21.79 21.77 21.94 21.57
Jun-3 21.13 21.35 21.53 20.88
Jun-4 22.02 21.78 22.15 21.76
Jun-5 22.07 21.81 22.07 21.78
Jun-6 21.86 22.20 22.22 21.86
Jun-9 22.20 22.25 22.37 22.02
Jun-10 22.53 22.84 22.93 22.50
Jun-11 22.67 22.63 22.89 22.58
Jun-12 22.95 23.09 23.13 22.77
Jun-13 22.96 22.82 23.08 22.70

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $5.22 per share, an increase this year of $0.14 per share, and an increase next year of $0.30 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.